Modesto Orozco I Co-Founder
Full Professor at UB and group leader of the IRN at IRB. ERC Advanced Grant recipient.Learn more
Victor Guallar I Co-Founder
ICREA Professor and group leader of the EAPM at BSC. ERC Advanced Grant recipient.Learn more
Scientific Advisory Board
Over 30 years of industry experience in drug discovery with multiple new chemical entities placed in clinical trials and approved on the market. Co-founder of Palau Pharma.
Professor of Computational Structural Biology at the Center for Molecular Biology at Heidelberg University (ZMBH) and leads the Molecular and Cellular Modeling group at Heidelberg Institute for Theoretical Studies (HITS).
Senior pharmaceutical R&D scientist with over 25 years’ experience in leading multi-disciplinary international research teams spanning target identification to clinical candidate selection.
Why choose us?
NBD scientific founders have developped cutting-edge technologies they have been successful to transfer to the private market. Combining these with best-of-market modelling software, they can propose unique, tailored and flexible services to their growing list of clients.
Our Drug Discovery
In addition to services in drug design & enzyme engineering projects, NBD is also leading a wide range of DD projects, ranging from cancer to schizophrenia and rare diseases. Some patents resulting from these Drug Discovery projects are currently being filed.
Dedication & Ethics
NBD scientifc founders are passionate about what they do, and leaders in their respective fields. Their top-notch scientific standards have gained the trust of public institutions that have funded their tech transfer to the market, and are already getting returns. In addition, NBD focuses on promoting gender equality.